4//SEC Filing
Aldeyra Therapeutics, Inc. 4
Accession 0000899243-16-011568
$ALDXCIK 0001341235operating
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 5:45 PM ET
Size
5.6 KB
Accession
0000899243-16-011568
Insider Transaction Report
Form 4
Clark David J
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2016-01-11+100,000→ 100,000 totalExercise: $6.76Exp: 2026-01-11→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares shall vest after 12 months of continuous service with the Issuer, the balance will vest in equal monthly installments over the next 36 months of continuous service with the Issuer.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001341235
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 5:45 PM ET
- Size
- 5.6 KB